跳至主要内容
临床试验/ISRCTN14959650
ISRCTN14959650已完成未知

Effects of prenylflavonoids of beer and dealcoholised beer on menopausal symptoms and estrogens

CIBER (Consorcio Centro de Investigación Biomédica en Red, M.P.)0 个研究点目标入组 37 人开始时间: 2018年1月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
37

研究概览

简要总结

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34209273/ (added 24/02/2023)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 11/05/2021:
  • Postmenopausal women between 45 and 70 years of age:
  • 1. FSH 23-116 U/L
  • 2. Estradiol (E2) <37 pg/ml
  • 3. Amenorrhea =12 months
  • Previous inclusion criteria:
  • Women between 45 and 70 years of age within 5 years of menopause:
  • 1. FSH >3 Miu/ml
  • 2. Estradiol (E2) =30 pg/ml
  • 3. Amenorrhea =12 months

排除标准

  • Current exclusion criteria as of 28/05/2021:
  • 1. Participants using estrogen therapy
  • 2. Participants who received silicon or polyphenol supplements
  • Previous exclusion criteria:
  • 1. Patients with known diseases affecting bone metabolism (rheumatoid arthritis, hyperthyroidism, surgical menopause, hypercortisolism, renal bone disease, chronic liver disease, among others)
  • 2. Use of drugs affecting bone metabolism (fluorides, bisphosphonates, calcitonin, teriparatide or parathormone, strontium ranelate, SERMs, estrogen therapy, anabolic steroids, chronic glucocorticoids (> 3 months), cytostatics, antiandrogens and antiepileptics)
  • 3. Participants who received silicon or polyphenol supplements

研究者

发起方
CIBER (Consorcio Centro de Investigación Biomédica en Red, M.P.)

相似试验

Evaluation of moderate daily intake of beer in... | 临床试验